vs

Side-by-side financial comparison of GLAUKOS Corp (GKOS) and BRAND HOUSE COLLECTIVE, INC. (TBHC). Click either name above to swap in a different company.

GLAUKOS Corp is the larger business by last-quarter revenue ($150.6M vs $103.5M, roughly 1.5× BRAND HOUSE COLLECTIVE, INC.). GLAUKOS Corp runs the higher net margin — 6.2% vs -3.6%, a 9.8% gap on every dollar of revenue. On growth, GLAUKOS Corp posted the faster year-over-year revenue change (41.2% vs -9.6%). Over the past eight quarters, GLAUKOS Corp's revenue compounded faster (25.4% CAGR vs -21.0%).

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

Soho House is an international private members’ club with a focus on the media, arts and fashion industries.

GKOS vs TBHC — Head-to-Head

Bigger by revenue
GKOS
GKOS
1.5× larger
GKOS
$150.6M
$103.5M
TBHC
Growing faster (revenue YoY)
GKOS
GKOS
+50.7% gap
GKOS
41.2%
-9.6%
TBHC
Higher net margin
GKOS
GKOS
9.8% more per $
GKOS
6.2%
-3.6%
TBHC
Faster 2-yr revenue CAGR
GKOS
GKOS
Annualised
GKOS
25.4%
-21.0%
TBHC

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
GKOS
GKOS
TBHC
TBHC
Revenue
$150.6M
$103.5M
Net Profit
$9.4M
$-3.7M
Gross Margin
77.9%
20.4%
Operating Margin
9.0%
-1.9%
Net Margin
6.2%
-3.6%
Revenue YoY
41.2%
-9.6%
Net Profit YoY
51.8%
EPS (diluted)
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GKOS
GKOS
TBHC
TBHC
Q1 26
$150.6M
Q4 25
$143.1M
$103.5M
Q3 25
$133.5M
$75.8M
Q2 25
$124.1M
$81.5M
Q1 25
$106.7M
$148.9M
Q4 24
$105.5M
$114.4M
Q3 24
$96.7M
$86.3M
Q2 24
$95.7M
$91.8M
Net Profit
GKOS
GKOS
TBHC
TBHC
Q1 26
$9.4M
Q4 25
$-133.7M
$-3.7M
Q3 25
$-16.2M
$-20.2M
Q2 25
$-19.7M
$-11.8M
Q1 25
$-18.1M
$7.9M
Q4 24
$-33.6M
$-7.7M
Q3 24
$-21.4M
$-14.5M
Q2 24
$-50.5M
$-8.8M
Gross Margin
GKOS
GKOS
TBHC
TBHC
Q1 26
77.9%
Q4 25
-1.1%
20.4%
Q3 25
78.4%
16.3%
Q2 25
78.3%
24.9%
Q1 25
77.2%
30.3%
Q4 24
72.9%
28.1%
Q3 24
76.6%
20.5%
Q2 24
76.4%
29.5%
Operating Margin
GKOS
GKOS
TBHC
TBHC
Q1 26
9.0%
Q4 25
-97.7%
-1.9%
Q3 25
-12.3%
-24.7%
Q2 25
-18.3%
-12.9%
Q1 25
-19.4%
6.2%
Q4 24
-27.2%
-2.1%
Q3 24
-25.5%
-15.4%
Q2 24
-31.3%
-8.2%
Net Margin
GKOS
GKOS
TBHC
TBHC
Q1 26
6.2%
Q4 25
-93.4%
-3.6%
Q3 25
-12.2%
-26.6%
Q2 25
-15.8%
-14.5%
Q1 25
-17.0%
5.3%
Q4 24
-31.8%
-6.7%
Q3 24
-22.1%
-16.8%
Q2 24
-52.8%
-9.6%
EPS (diluted)
GKOS
GKOS
TBHC
TBHC
Q1 26
Q4 25
$-2.34
$-0.16
Q3 25
$-0.28
$-0.90
Q2 25
$-0.34
$-0.54
Q1 25
$-0.32
$0.61
Q4 24
$-0.56
$-0.59
Q3 24
$-0.39
$-1.11
Q2 24
$-1.00
$-0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GKOS
GKOS
TBHC
TBHC
Cash + ST InvestmentsLiquidity on hand
$276.7M
$6.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$670.9M
$-44.0M
Total Assets
$893.3M
$229.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GKOS
GKOS
TBHC
TBHC
Q1 26
$276.7M
Q4 25
$90.8M
$6.5M
Q3 25
$98.2M
$3.6M
Q2 25
$100.8M
$3.5M
Q1 25
$114.3M
$3.8M
Q4 24
$169.6M
$6.8M
Q3 24
$100.1M
$4.5M
Q2 24
$68.1M
$3.8M
Total Debt
GKOS
GKOS
TBHC
TBHC
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
$64.0M
Q4 24
$85.8M
Q3 24
$61.4M
Q2 24
$47.5M
Stockholders' Equity
GKOS
GKOS
TBHC
TBHC
Q1 26
$670.9M
Q4 25
$656.2M
$-44.0M
Q3 25
$769.5M
$-35.2M
Q2 25
$765.1M
$-16.2M
Q1 25
$764.0M
$-19.0M
Q4 24
$766.9M
$-27.1M
Q3 24
$668.5M
$-19.7M
Q2 24
$665.2M
$-5.5M
Total Assets
GKOS
GKOS
TBHC
TBHC
Q1 26
$893.3M
Q4 25
$893.5M
$229.2M
Q3 25
$999.4M
$221.9M
Q2 25
$987.0M
$225.4M
Q1 25
$966.2M
$242.2M
Q4 24
$974.8M
$279.8M
Q3 24
$926.5M
$266.2M
Q2 24
$919.7M
$242.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GKOS
GKOS
TBHC
TBHC
Operating Cash FlowLast quarter
$-25.9M
Free Cash FlowOCF − Capex
$-26.8M
FCF MarginFCF / Revenue
-25.9%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-18.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GKOS
GKOS
TBHC
TBHC
Q1 26
Q4 25
$6.8M
$-25.9M
Q3 25
$-10.1M
$-7.0M
Q2 25
$7.0M
$-3.1M
Q1 25
$-18.5M
$19.8M
Q4 24
$507.0K
$-12.6M
Q3 24
$-9.6M
$-12.7M
Q2 24
$-18.4M
$-13.7M
Free Cash Flow
GKOS
GKOS
TBHC
TBHC
Q1 26
Q4 25
$3.9M
$-26.8M
Q3 25
$-11.7M
$-7.4M
Q2 25
$5.8M
$-3.6M
Q1 25
$-20.5M
$19.0M
Q4 24
$-1.2M
$-13.1M
Q3 24
$-11.0M
$-13.2M
Q2 24
$-20.5M
$-14.4M
FCF Margin
GKOS
GKOS
TBHC
TBHC
Q1 26
Q4 25
2.7%
-25.9%
Q3 25
-8.8%
-9.8%
Q2 25
4.7%
-4.5%
Q1 25
-19.2%
12.8%
Q4 24
-1.2%
-11.5%
Q3 24
-11.4%
-15.2%
Q2 24
-21.4%
-15.7%
Capex Intensity
GKOS
GKOS
TBHC
TBHC
Q1 26
Q4 25
2.0%
0.9%
Q3 25
1.2%
0.6%
Q2 25
0.9%
0.7%
Q1 25
1.8%
0.5%
Q4 24
1.6%
0.4%
Q3 24
1.5%
0.5%
Q2 24
2.2%
0.8%
Cash Conversion
GKOS
GKOS
TBHC
TBHC
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
2.51×
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons